AnswerY Delivers 19:1 ROI

Amplity Intel

Neurology Rare Disease

AnswerY Delivers 19:1 ROI

Download PDF

Proprietary database + platform enable remote sales team to engage with an expanded list of HCPs who are treating patients earlier in their journey, specifically those presenting with multiple symptoms suggestive of the targeted rare disease. The result was faster treatment + 19:1 ROI for the client.

Download PDF

The Power of This Partnership

2 Weeks To Hit Annual Patient Identification Goal

19:1

ROI On AnswerY Investment

The Ask

CLIENT

U.S.

Mid-Sized BioPharma

Pinpoint Rare Disease Patients

Identify + prioritize HCPs to support a rare neurological disease medication launch.

Uncover New Potential Patients

Enhance patient journey mapping to speed up therapy initiation + improve outcomes.

The Approach

TOOLS

AnswerY

Remote Team

Patient Finding

Symptom Intersection Strategy

Pinpoint patients with specific symptom profiles by identifying the right HCPs.

Engage Right HCPs With Unique Dataset

Deploy remote sales team to use next-level intel to uncover patients who may have been overlooked in traditional claims data or ICD codes.

The Results

OUTCOME

Rare Patients Identified

Fast Tracked Care

Team Alignment

Quick Patient Identification

Uncovered more rare disease patients than company’s initial projection in 2 weeks by identifying HCPs not found in more commodified datasets, e.g. claims.

19:1 ROI

Delivered significant return on investment.

Fast Tracked Treatment

Improved HCP’s ability to identify patients earlier in their diagnosis, leading to quicker treatment + better outcomes.

Data + Sales Synergy

Drove exceptional results by combining AnswerY with high-performing remote sales team.